Can MTRR rs1801394 GG impair methylcobalamin regeneration despite high serum B12?

The methionine synthase reductase (MTRR) gene plays an indispensable role in maintaining the cellular methylation cycle. Genetic variations in this gene can significantly alter how the body processes vitamin B12, regardless of circulating levels.

Mechanistic explanations

• Enzymatic Impairment: The MTRR rs1801394 (A66G) GG genotype causes an isoleucine-to-methionine substitution (I22M) within the enzyme’s FMN-binding domain. This structural alteration weakens the binding affinity between MTRR and the methionine synthase (MTR) complex.
• Cofactor Recycling Failure: This weakened affinity leads to a several-fold reduction in reactivation efficiency, hindering the regeneration of active methylcobalamin from cob(I)alamin. Because methylcobalamin is an essential cofactor for MTR, this kinetic bottleneck causes MTR to stall in its inactive state.
• Metabolic Accumulation: Impaired MTR activity limits the remethylation of homocysteine to methionine. Under systemic stress or suboptimal nutrient status, this metabolic block compromises overall methylation potential and leads to elevated plasma homocysteine levels.

Clinical and diagnostic considerations

• The Serum-Intracellular Disconnect: Routine total serum vitamin B12 assays measure circulating cobalamin bound to transport proteins, which does not accurately reflect intracellular metabolic activity or tissue-level uptake.
• Inefficacy of Systemic Flooding: Elevating systemic B12 through supplementation increases circulating levels but does not repair or bypass the intracellular transport and processing block caused by the MTRR rs1801394 GG variant.
• Functional Biomarkers: Because high serum B12 can coexist with functional intracellular deficiency, evaluating cellular B12 status requires measuring functional biomarkers, specifically methylmalonic acid (MMA) and homocysteine.

Bottom line

• The MTRR rs1801394 GG genotype impairs intracellular methylcobalamin regeneration and compromises methionine synthase activity; because systemic supplementation elevates serum B12 without resolving this underlying enzymatic bottleneck, high serum B12 levels do not exclude functional intracellular deficiency.